Pharmaceutical Preparations · DE · CIK 1787306
Develops and commercializes treatments for dermatological diseases with high unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 7 sold $5.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Leonard Keith RDirector | Sell | 39,272 | $25.39 | $997K |
| Mar 2, 2026 | Watanabe ToddSee Remarks | Sell | 36,281 | $25.16 | $913K |
| Mar 2, 2026 | Welgus Howard G.Director | Sell | 10,000 | $25.65 | $257K |
| Mar 2, 2026 | Matsuda MasaruSee Remarks | Sell | 6,553 | $25.16 | $165K |
| Mar 2, 2026 | Burnett PatrickSee Remarks | Sell | 6,106 | $25.16 | $154K |
| Mar 2, 2026 | Edwards Larry ToddSee Remarks | Sell | 3,584 | $25.16 | $90K |
| Mar 2, 2026 | Vairavan LathaSVP Chief Financial Officer | Sell | 2,772 | $25.16 | $70K |
| Mar 2, 2026 | Matsuda MasaruSee Remarks | Sell | 1,987 | $25.70 | $51K |
| Mar 2, 2026 | Watanabe ToddSee Remarks | Sell | 1,068 | $25.91 | $28K |
| Mar 2, 2026 | Matsuda MasaruSee Remarks | Sell | 193 | $25.91 | $5K |
| Mar 2, 2026 | Burnett PatrickSee Remarks | Sell | 181 | $25.91 | $5K |
| Mar 2, 2026 | Edwards Larry ToddSee Remarks | Sell | 103 | $25.91 | $3K |
| Mar 2, 2026 | Vairavan LathaSVP Chief Financial Officer | Sell | 81 | $25.91 | $2K |
| Feb 27, 2026 | Matsuda MasaruSee Remarks | Sell | 3,325 | $27.95 | $93K |
| Feb 4, 2026 | Burnett PatrickSee Remarks | Sell | 9,794 | $25.81 | $253K |
| Feb 2, 2026 | Watanabe ToddSee Remarks | Sell | 19,833 | $25.50 | $506K |
| Feb 2, 2026 | Matsuda MasaruSee Remarks | Sell | 19,379 | $25.24 | $489K |
| Feb 2, 2026 | Welgus Howard G.Director | Sell | 10,000 | $25.05 | $251K |
| Feb 2, 2026 | Matsuda MasaruSee Remarks | Sell | 8,562 | $24.97 | $214K |
| Feb 2, 2026 | Matsuda MasaruSee Remarks | Sell | 7,983 | $25.50 | $204K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.